Brief: HBM IPOs Of Instil Bio And Connect Biopharma Ups Net Asset Value By 1.5%
March 22 (Reuters) - HBM HEALTHCARE INVESTMENTS AG HBMN.S :
* IPOS OF INSTIL BIO AND CONNECT BIOPHARMA INCREASE NET
ASSET
VALUE PER HBM SHARE BY CHF 4.55 (+1.5%)
* HBM HEALTHCARE INVESTMENTS AG - INSTIL BIO RAISED USD 320
MILLION IN NEW CAPITAL BY ISSUING 16 MILLION SHARES AT A PRICE
OF USD 20.00 PER SHARE
* HBM HEALTHCARE INVESTMENTS AG - ON FIRST DAY OF TRADING,
SHARE
PRICE ROSE TO USD 26.44 (+32.2%)
Source text for Eikon: ID:nEQ9m9DcMa
Further company coverage: HBMN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on HBM Healthcare Investments AG
See all newsSwiss stocks - Factors to watch on October 23
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics